Familial hypercholesterolemia and cardiovascular disease in older individuals

Imagem de Miniatura
Arquivos
art_COUTINHO_Familial_hypercholesterolemia_and_cardiovascular_disease_in_older_individuals_2021.PDF (901.33 KB)
Citações na Scopus
13
Tipo de produção
article
Data de publicação
2021
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
ELSEVIER IRELAND LTD
Autores
Citação
ATHEROSCLEROSIS, v.318, p.32-37, 2021
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background and aims: Familial hypercholestemlemia (FH) is characterized by high LDL-cholesterol (LDL-C) and early atherosclerotic cardiovascular disease (ASCVD). With a lipid lowering therapy (LLT), most individuals with FH may have a longer ASCVD-free survival. However, there is scant data about older individuals with FH. Methods: We compared characteristics of genetically defined FH older individuals with age-matched non-FH counterparts. Results: From 4111 genotyped individuals, 462 older than 60 years were included (198 positive and 264 negative for FH variants). There were no differences regarding median age [%25; 75%] 66.0 (62.0; 71.0) and 66.0 (62.2; 71.0) years, p = 0.68 for FH and non-FH, respectively. In both groups, there was a higher frequency of females, however, there were more males in the FH group 37.4% vs. 24.2%, p = 0.002. No differences were seen between FH and non-FH in LLT use: 88.5% vs. 91.5%, p = 0.29. Despite a longer LLT duration in FH patients (with 11.0 (7.0; 20.0) vs. 7.0 (3.0; 13.0) years, p < 0.001), treatment was started late in both groups: at 54.0 (47.0; 61.0) and 59.0 (52.0; 64.0) years, p < 0.001, in FH and non-FH, respectively. FH had greater frequencies of previous and early ASCVD (40.9% vs. 27.3%, p = 0.002, and 22.2% vs. 9.0%, p < 0.001). In FH, male sex [HR (95%C01 2.67 (1.50-4.73), p = 0.001, and LLT onset age 0.96 (0.93-0.99), p = 0.009, were independently associated with ASCVD. Conclusions: Among hypercholesterolemic older individuals participating in a cascade screening program, the genetic diagnosis of FH was associated with higher ASCVD rates, emphasizing the relevance of a monogenic defect as the cause of long-lasting hypercholesterolemia and ASCVD risk, particularly in men.
Palavras-chave
Familial hypercholesterolemia, Cardiovascular disease, Older individuals, Ageing, Monogenic disease, Atherosclerosis, Cholesterol, Statins
URI
https://observatorio.fm.usp.br/handle/OPI/39781
Referências
  1. Alonso R, 2014, J AM COLL CARDIOL, V63, P1983, DOI 10.1016/j.jacc.2014.01.063
  2. American Academy of Family Physicians AdA National Council on the Aging American Academy of Family Physicians ADA National Council on the Aging, 2002, NUTR SCREEN INT RES
  3. Austin MA, 2004, AM J EPIDEMIOL, V160, P421, DOI 10.1093/aje/kwh237
  4. Bertakis KD, 2000, J FAM PRACTICE, V49, P147
  5. Besseling J, 2016, J AM COLL CARDIOL, V68, P252, DOI 10.1016/j.jacc.2016.04.054
  6. Besseling J, 2014, ATHEROSCLEROSIS, V233, P219, DOI 10.1016/j.atherosclerosis.2013.12.020
  7. Defesche JC, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.93
  8. deGoma EM, 2016, CIRC-CARDIOVASC GENE, V9, P240, DOI 10.1161/CIRCGENETICS.116.001381
  9. Dewey FE, 2017, NEW ENGL J MED, V377, P211, DOI 10.1056/NEJMoa1612790
  10. Ek S, 2015, HEALTH PROMOT INT, V30, P736, DOI 10.1093/heapro/dat063
  11. Gallo A, 2017, J CLIN LIPIDOL, V11, P704, DOI 10.1016/j.jacl.2017.03.016
  12. Grundy S.M., J AM COLL CARDIOL, V73
  13. Hamczyk MR, 2020, J AM COLL CARDIOL, V75, P919, DOI 10.1016/j.jacc.2019.11.062
  14. Hyttinen L, 2008, INT J TECHNOL ASSESS, V24, P228, DOI 10.1017/S0266462308080318
  15. Jannes CE, 2015, ATHEROSCLEROSIS, V238, P101, DOI 10.1016/j.atherosclerosis.2014.11.009
  16. Johnson KW, 2018, CUREUS, V10, DOI 10.7759/cureus.2452
  17. Khera AV, 2016, NEW ENGL J MED, V375, P2349, DOI 10.1056/NEJMoa1605086
  18. Khera AV, 2016, J AM COLL CARDIOL, V67, P2578, DOI 10.1016/j.jacc.2016.03.520
  19. Lacaze P, 2020, CIRC-GENOM PRECIS ME, V13, DOI 10.1161/CIRCGEN.120.002938
  20. Luirink I.K., 2019, N ENGL J MED, V381
  21. Mach F, 2019, ATHEROSCLEROSIS, V290, P140, DOI [10.1016/j.atherosclerosis.2019.08.014, 10.1093/eurheartj/ehz455]
  22. Miname MH, 2019, PROG CARDIOVASC DIS, V62, P414, DOI 10.1016/j.pcad.2019.10.003
  23. Miname MH, 2019, JACC-CARDIOVASC IMAG, V12, P1797, DOI 10.1016/j.jcmg.2018.09.019
  24. Mundal LJ, 2018, HEART, V104, P1600, DOI 10.1136/heartjnl-2017-312706
  25. MURANO S, 1993, J AM GERIATR SOC, V41, P253, DOI 10.1111/j.1532-5415.1993.tb06702.x
  26. Neil HAW, 1999, ATHEROSCLEROSIS, V142, P105
  27. Paquette M, 2017, J CLIN LIPIDOL, V11, P80, DOI 10.1016/j.jacl.2016.10.004
  28. Perak AM, 2016, CIRCULATION, V134, P9, DOI 10.1161/CIRCULATIONAHA.116.022335
  29. de Isla LP, 2017, CIRCULATION, V135, P2133, DOI 10.1161/CIRCULATIONAHA.116.024541
  30. de Isla LP, 2016, J AM COLL CARDIOL, V67, P1278, DOI 10.1016/j.jacc.2016.01.008
  31. Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30
  32. Ridker PM, 2018, J CLIN LIPIDOL, V12, P958, DOI 10.1016/j.jacl.2018.03.088
  33. Santos RD, 2020, J AM COLL CARDIOL, V75, P565, DOI 10.1016/j.jacc.2019.12.020
  34. Santos RD, 2016, LANCET DIABETES ENDO, V4, P850, DOI 10.1016/S2213-8587(16)30041-9
  35. Sharifi M, 2017, ATHEROSCLEROSIS, V263, P405, DOI 10.1016/j.atherosclerosis.2017.05.015
  36. Shaw LJ, 2006, J AM COLL CARDIOL, V47, p4S, DOI 10.1016/j.jacc.2005.01.072
  37. Shetty P, 2012, LANCET, V379, P1285, DOI 10.1016/S0140-6736(12)60541-8
  38. Silva PRS, 2017, ATHEROSCLEROSIS, V263, P257, DOI 10.1016/j.atherosclerosis.2017.06.917
  39. SLACK J, 1969, LANCET, V2, P1380
  40. Trinder M., 2020, JAMA CARDIOL
  41. Trinder M, 2019, J AM COLL CARDIOL, V74, P512, DOI 10.1016/j.jacc.2019.05.043
  42. Versmissen J, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2423
  43. Vrablik M, 2017, PHYSIOL RES, V66, pS1, DOI 10.33549/physiolres.933600

Coleções
Artigos e Materiais de Revistas Científicas - FM/MCP
Artigos e Materiais de Revistas Científicas - HC/InCor
Artigos e Materiais de Revistas Científicas - HU
Artigos e Materiais de Revistas Científicas - LIM/13
Artigos e Materiais de Revistas Científicas - ODS/03